MEDI4736
D419LC00001
Phase 3 mab completed
Quick answer
MEDI4736 for Squamous Cell Carcinoma of the Head and Neck is a Phase 3 program (mab) at AstraZeneca with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca
- Indication
- Squamous Cell Carcinoma of the Head and Neck
- Phase
- Phase 3
- Modality
- mab
- Status
- completed